Received Feb 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Dose 1 Shingrix was given in 2021 and wants to get her 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in 2021). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Dose 1 Shingrix was given in 2021 and wants to get her 2nd dose). The outcome of the incomplete course of vaccination was unknown. Additional Information: GSK Receipt Date: 06-FEB-2025 The registered pharmacist reported that the patient wanted to get her 2nd dose of Shingrix and the patient asked if she needed to restart Shingrix series since 1st dose was given in 2021. She stated she was told she had to restart by another pharmacy. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.